Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks

MLA

Charmaine Donald, et al. “Krebs von Den Lungen 6 (KL-6) as a Marker for Disease Severity and Persistent Radiological Abnormalities Following COVID-19 Infection at 12 Weeks.” PLOS ONE, vol. 16, Apr. 2021, p. e0249607. EBSCOhost, https://doi.org/10.1371/journal.pone.0249607.

APA

Charmaine Donald, Shaney L Barratt, Marie Attwood, Fergus Hamilton, Max Lyon, Anna J Morley, David T Arnold, & Alexandra S L Dipper. (2021). Krebs von den Lungen 6 (KL-6) as a marker for disease severity and persistent radiological abnormalities following COVID-19 infection at 12 weeks. PLOS ONE, 16, e0249607. https://doi.org/10.1371/journal.pone.0249607

Chicago

Charmaine Donald, Shaney L Barratt, Marie Attwood, Fergus Hamilton, Max Lyon, Anna J Morley, David T Arnold, and Alexandra S L Dipper. 2021. “Krebs von Den Lungen 6 (KL-6) as a Marker for Disease Severity and Persistent Radiological Abnormalities Following COVID-19 Infection at 12 Weeks.” PLOS ONE 16 (April): e0249607. doi:10.1371/journal.pone.0249607.